Clinical Trial Update: Study to Determine the Efficacy, Safety, Tolerability & Pharmacokinetics of RO 205-2349 in Patients With Type 2 Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase 2 trial update for RO 205-2349 in patients with type 2 diabetes mellitus assessing efficacy, safety, tolerability, and pharmacokinetics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Ro 205-2349

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Diabetes | Phase 2 | Status: COMPLETED